Anuh Pharma Limited (ANUHPHR.BO)
INR 221.35
(-0.23%)
INR 221.35
(-0.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.54 Billion INR | -5.68% |
| 2022 | 1.63 Billion INR | 22.76% |
| 2021 | 1.33 Billion INR | -6.05% |
| 2020 | 1.41 Billion INR | -13.51% |
| 2019 | 1.64 Billion INR | 116.95% |
| 2018 | 756.7 Million INR | 27.01% |
| 2017 | 595.77 Million INR | 23.74% |
| 2016 | 481.45 Million INR | -20.01% |
| 2015 | 601.88 Million INR | -10.68% |
| 2014 | 673.87 Million INR | -12.91% |
| 2013 | 773.77 Million INR | 27.89% |
| 2012 | 605.04 Million INR | 21.43% |
| 2011 | 498.28 Million INR | -20.45% |
| 2010 | 626.37 Million INR | 11.27% |
| 2009 | 562.91 Million INR | 42.58% |
| 2008 | 394.79 Million INR | -29.95% |
| 2007 | 563.59 Million INR | 59.46% |
| 2006 | 353.44 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q4 | 1.54 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.42 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.54 Billion INR | -5.68% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.63 Billion INR | 22.76% |
| 2022 Q2 | 1.16 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 1.63 Billion INR | 0.0% |
| 2021 FY | 1.33 Billion INR | -6.05% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.39 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.33 Billion INR | 0.0% |
| 2020 FY | 1.41 Billion INR | -13.51% |
| 2020 Q4 | 1.42 Billion INR | 0.0% |
| 2020 Q2 | 1.78 Billion INR | 0.0% |
| 2019 Q2 | 949.06 Million INR | 0.0% |
| 2019 Q4 | 1.64 Billion INR | 0.0% |
| 2019 FY | 1.64 Billion INR | 116.95% |
| 2018 Q2 | 906.7 Million INR | 0.0% |
| 2018 FY | 756.7 Million INR | 27.01% |
| 2018 Q4 | 756.7 Million INR | 0.0% |
| 2017 FY | 595.77 Million INR | 23.74% |
| 2017 Q4 | 595.77 Million INR | 0.0% |
| 2017 Q2 | 446.92 Million INR | 0.0% |
| 2016 Q4 | 481.45 Million INR | 0.0% |
| 2016 Q2 | 601.7 Million INR | 0.0% |
| 2016 FY | 481.45 Million INR | -20.01% |
| 2015 Q4 | 601.88 Million INR | 0.0% |
| 2015 Q2 | 927.8 Million INR | 0.0% |
| 2015 FY | 601.88 Million INR | -10.68% |
| 2014 Q2 | 867 Million INR | 0.0% |
| 2014 FY | 673.87 Million INR | -12.91% |
| 2014 Q4 | 673.87 Million INR | 0.0% |
| 2013 Q4 | 773.77 Million INR | 0.0% |
| 2013 FY | 773.77 Million INR | 27.89% |
| 2013 Q2 | 667.7 Million INR | 0.0% |
| 2012 Q4 | 605.04 Million INR | 0.0% |
| 2012 FY | 605.04 Million INR | 21.43% |
| 2012 Q2 | 1.41 Billion INR | 0.0% |
| 2011 FY | 498.28 Million INR | -20.45% |
| 2010 FY | 626.37 Million INR | 11.27% |
| 2009 FY | 562.91 Million INR | 42.58% |
| 2008 FY | 394.79 Million INR | -29.95% |
| 2007 FY | 563.59 Million INR | 59.46% |
| 2006 FY | 353.44 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -5909.949% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -55.027% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -7258.842% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2779.231% |
| Sunil Healthcare Limited | 902.83 Million INR | -71.086% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -72485.573% |
| MedPlus Health Services Limited | 14.27 Billion INR | 89.179% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -53.796% |
| Patidar Buildcon Limited | 25.57 Million INR | -5940.282% |
| Roopa Industries Limited | 493.08 Million INR | -213.255% |
| Smruthi Organics Limited | 485.72 Million INR | -218.006% |
| Trident Lifeline Limited | 331.26 Million INR | -366.284% |
| PANJON LTD. | 25.38 Million INR | -5985.258% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -641.035% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -855.392% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -10211.91% |
| Crestchem Limited | 23.94 Million INR | -6350.165% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -11422.723% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -1206.532% |
| Tyche Industries Limited | 101.64 Million INR | -1419.683% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 17.013% |
| Trimurthi Limited | 101.36 Thousand INR | -1523796.014% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -664.762% |
| Norris Medicines Limited | 278.17 Million INR | -455.273% |
| Zenlabs Ethica Limited | 301.35 Million INR | -412.56% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -429.931% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 7.04% |
| Parmax Pharma Limited | 117.56 Million INR | -1213.814% |
| Veerhealth Care Limited | 62.78 Million INR | -2360.371% |
| Deccan Health Care Limited | 111.33 Million INR | -1287.351% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 9.892% |
| Makers Laboratories Limited | 569.18 Million INR | -171.377% |
| Lactose (India) Limited | 536.39 Million INR | -187.962% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -85.396% |
| Zenith Healthcare Limited | 24.03 Million INR | -6326.549% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -896.112% |
| Bacil Pharma Limited | 1.12 Million INR | -136713.198% |
| PRAVEG LIMITED | 767.53 Million INR | -101.244% |
| Denis Chem Lab Limited | 289.82 Million INR | -432.955% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 10.001% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -666.211% |
| Colinz Laboratories Limited | 24.1 Million INR | -6307.886% |
| Godavari Drugs Limited | 957.86 Million INR | -61.257% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -516495.652% |
| Zenotech Laboratories Limited | 156.64 Million INR | -886.046% |
| Panchsheel Organics Limited | 340.2 Million INR | -354.031% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -216.282% |
| Vivanza Biosciences Limited | 148.63 Million INR | -939.232% |
| Phaarmasia Limited | 211.49 Million INR | -630.335% |
| Sastasundar Ventures Limited | 1.5 Billion INR | -2.934% |
| Medi-Caps Limited | 63.01 Million INR | -2351.157% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -1212.059% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -682.59% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -36.583% |
| Mercury Laboratories Limited | 171.18 Million INR | -802.29% |
| Gennex Laboratories Limited | 535.21 Million INR | -188.6% |
| BDH Industries Limited | 312.53 Million INR | -394.223% |
| Coral Laboratories Limited | 281.83 Million INR | -448.051% |
| Concord Drugs Limited | 249.88 Million INR | -518.13% |
| Bharat Parenterals Limited | 2.65 Billion INR | 41.855% |
| Beryl Drugs Limited | 85.63 Million INR | -1703.705% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -781.799% |
| Evoq Remedies Limited | 116.23 Million INR | -1228.912% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -870.215% |
| Transchem Limited | 6.72 Million INR | -22885.432% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -17310.065% |
| Parnax Lab Limited | 1.17 Billion INR | -31.938% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -3580.122% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -46.043% |
| Cian Healthcare Limited | 1.03 Billion INR | -49.332% |
| Trinity League India Limited | 876 Thousand INR | -176226.598% |
| Syschem (India) Limited | 1.07 Billion INR | -44.26% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 24.396% |
| Natural Capsules Limited | 1.47 Billion INR | -4.563% |
| Auro Laboratories Limited | 433.09 Million INR | -256.646% |